Skip to main content
78°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Epizyme Inc
(NQ:
EPZM
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Epizyme Inc
< Previous
1
2
3
4
5
Next >
Epizyme Raises $85M Via Equity Issued At 21% Discount
January 27, 2022
Epizyme Inc (NASDAQ: EPZM) has priced its underwritten public offering of 56.7 million shares at
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 27, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 27, 2022
Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!
Via
InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
January 27, 2022
Gainers The National Security Group, Inc. (NASDAQ: NSEC) rose 63.7% to $15.10 in pre-market trading after VR Insurance Holdings announced acquisition of The National...
Via
Benzinga
Epizyme Announces Pricing of Public Offering of Common Stock
January 27, 2022
From
Epizyme, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 26, 2022
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM
Via
Benzinga
Epizyme Announces Proposed Public Offering of Common Stock
January 26, 2022
From
Epizyme, Inc.
Via
Business Wire
Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates
January 10, 2022
From
Epizyme, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Epizyme Presents Updates from SYMPHONY-1 Tazemetostat + R2 Combination Study in Relapsed/Refractory Follicular Lymphoma at the 2021 ASH Annual Meeting
December 12, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual Meeting
December 11, 2021
From
Epizyme, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
Gainers Quoin Pharmaceuticals (NASDAQ:
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
Epizyme to Present New Data from Its Oncology Portfolio at 2021 American Society of Hematology Annual Meeting
December 02, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Announces Updates to Its Board of Directors
November 18, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme to Participate in Jefferies London Healthcare Conference
November 12, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme's Return On Capital Employed Insights
November 10, 2021
Benzinga Pro data, Epizyme (NASDAQ:EPZM) reported Q3 sales of $5.20 million. Earnings fell to a loss of $64.16 million, resulting in a 10.09% decrease from last quarter. In Q2,...
Via
Benzinga
Epizyme, inc (EPZM) Q3 2021 Earnings Call Transcript
November 09, 2021
EPZM earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update
November 09, 2021
From
Epizyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 05, 2021
From
Epizyme, Inc.
Via
Business Wire
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Epizyme Receives Fast Track Designation from U.S. FDA and Announces Initiation of Phase 1/1b Study of its Novel SETD2 Inhibitor, EZM0414
November 04, 2021
From
Epizyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Epizyme Announces Date of Third Quarter 2021 Financial Results
November 02, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Launches In My Blood Online Resource to Empower People Living with Follicular Lymphoma to Play a Proactive Role in Treatment-Decision Making
November 01, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 07, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Announces Data from TAZVERIK® (Tazemetostat) Clinical Programs to be Presented During Poster Sessions at 2021 ESMO Virtual Congress
September 14, 2021
From
Epizyme, Inc.
Via
Business Wire
Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 20, 2021
From
Epizyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.